Dr. Wong has over 20 years of experience in the pharmaceutical and biotechnology industries including 15+ years in various business development and licensing functions. Dr. Wong was the Vice President, Head of Business Development and Licensing at Piramal Imaging where he successfully completed a number of high value strategic transactions involving the commercial launch of Neuraceq, an amyloid plaque PET imaging agent. He also led the in licensing of a tau PET imaging program into Piramal Imaging. Prior to Piramal Imaging, he led the Corporate Development function at YM BioSciences where he executed a partnering campaign for a Phase 2/3 JAK inhibitor that resulted in the acquisition of the company by Gilead for over $510M USD. His business development experiences also include executing transactions and managing partnerships at OSI Pharmaceuticals and AnorMED Inc. Dr. Wong holds a Ph.D. in chemistry from the University of British Columbia and an MBA from the Leeds School of Business at the University of Colorado at Boulder.
Business and Management